Why did Teradyne's Q3 2025 earnings decline year over year even though revenue grew?

Revenue rose 4% to $769.2 million, but GAAP net income fell to $119.6 million from $145.6 million, and GAAP EPS dropped to $0.75 from $0.89. Operating expenses grew faster than gross profit: selling and administrative costs rose to $169.1 million from $157.6 million, engineering and development rose to $124.8 million from $117.5 million, and restructuring charges increased. Gross margin also slipped to 58.4% from 59.2%. The share count fell, which partially offset the decline in net income.

What is driving the expected Q4 2025 revenue increase?

Management attributes the outlook to strong AI-related test demand across compute, networking, and memory. The company expects Q4 2025 sales to rise about 25% sequentially and 27% from Q4 2024, with revenue guided to $920 million to $1,000 million. The guidance depends on continued SoC and memory test orders being shipped and accepted within the quarter, so timing risk remains.

Why did cash fall and debt increase in the quarter?

Teradyne drew $200 million on its revolving credit facility in Q3, which is classified as short-term debt on the balance sheet. Cash also declined because the company repurchased $243.8 million of common stock and invested $20.2 million in businesses, while operating cash flow was only $49.1 million due to a large receivables increase. Year to date, cash and equivalents fell by $280.7 million.

What should investors watch regarding receivables and working capital?

Accounts receivable climbed to $593.8 million from $471.4 million at year-end 2024, and the Q3 increase alone was $161.3 million. Inventories and prepayments also rose. Because the Q4 guidance implies a large revenue step-up, investors should watch whether receivables convert to cash in Q4 and whether the company's working capital and operating cash flow recover to support buybacks and dividends.

How do GAAP and non-GAAP results differ for Teradyne this quarter?

Non-GAAP net income of $135.9 million ($0.85 per diluted share) excludes acquired intangible amortization, equity method investment amortization of $7.7 million, restructuring and other charges of $6.6 million, ERP-related expenses, and a pension gain, with a related tax adjustment. The gap between GAAP EPS of $0.75 and non-GAAP EPS of $0.85 is mostly equity method amortization and restructuring. Management presents non-GAAP measures as supplemental, not as substitutes for GAAP results.

TER 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed October 29, 2025. Cited figures are marked; the original filing is the authoritative source.

Teradyne (NASDAQ: TER) reported third-quarter 2025 results on October 28, 2025 with revenue of $769.2 million^a, up about 4% from $737.3 million in Q3 2024 and up roughly 18% sequentially from $651.8 million in Q2 2025.

The quarter landed at the high end of management's guidance, driven by Semiconductor Test ($606 million^b), which management said was stronger than expected on demand for System-on-a-Chip (SoC) test for AI applications and strong memory test. GAAP net income was $119.6 million, or $0.75 per diluted share, compared with $0.89 a year earlier, while non-GAAP EPS was $0.85 versus $0.90 in Q3 2024. Operating margin improved sequentially, with GAAP income from operations of $145.3 million (18.9% of revenue) versus $90.7 million in Q2, though year-over-year GAAP operating income declined from $152.1 million.

The balance sheet and capital allocation picture shifted during the quarter. Teradyne drew $200 million^c on its revolving credit facility, now shown as short-term debt, and spent $243.8 million repurchasing common stock in Q3 (about $518.7 million year to date). Cash and equivalents fell to $272.7 million from $553.4 million at year-end 2024, and operating cash flow for the quarter was only $49.1 million, pressured by a $161.3 million increase in accounts receivable.

Goodwill and acquired intangibles rose meaningfully after acquisitions, which consumed $144.4 million^d in cash during the nine months. Management guided Q4 2025 revenue to $920 million to $1,000 million, implying roughly 25% sequential growth at the midpoint, with GAAP EPS of $1.12 to $1.39 and non-GAAP EPS of $1.20 to $1.46. The guidance signals a sharp acceleration tied to AI-related compute and memory test demand, which investors will need to validate against customer timing, margins, and working capital given the recent receivables build.

02—Key points

Key Highlights

Q3 2025 revenue of $769.2 million, up 4% year over year and about 18% sequentially, at the high end of guidance; Semiconductor Test contributed $606 million.
GAAP EPS of $0.75 versus $0.89 a year ago; non-GAAP EPS of $0.85 versus $0.90, reflecting lower year-over-year profitability despite revenue growth.
Q4 2025 guidance of $920 million to $1,000 million in revenue, roughly 25% sequential growth at the midpoint, with non-GAAP EPS of $1.20 to $1.46.
Operating cash flow weakened to $49.1 million in Q3 from $166.3 million a year earlier, driven by a $161.3 million rise in accounts receivable.
Teradyne repurchased $243.8 million of stock in Q3 and $518.7 million year to date, while drawing $200 million on its revolver, now reported as short-term debt.
Cash and equivalents declined to $272.7 million from $553.4 million at year-end 2024, reducing liquidity headroom as buybacks and acquisitions continued.
Robotics revenue was $75 million, and a planned ERP implementation added about $1.1 million of quarterly expense; restructuring charges rose to $6.6 million, mainly employee severance.

03—Questions

Frequently Asked Questions

Why did Teradyne's Q3 2025 earnings decline year over year even though revenue grew?
Revenue rose 4% to $769.2 million, but GAAP net income fell to $119.6 million from $145.6 million, and GAAP EPS dropped to $0.75 from $0.89. Operating expenses grew faster than gross profit: selling and administrative costs rose to $169.1 million from $157.6 million, engineering and development rose to $124.8 million from $117.5 million, and restructuring charges increased. Gross margin also slipped to 58.4% from 59.2%. The share count fell, which partially offset the decline in net income.
What is driving the expected Q4 2025 revenue increase?
Management attributes the outlook to strong AI-related test demand across compute, networking, and memory. The company expects Q4 2025 sales to rise about 25% sequentially and 27% from Q4 2024, with revenue guided to $920 million to $1,000 million. The guidance depends on continued SoC and memory test orders being shipped and accepted within the quarter, so timing risk remains.
Why did cash fall and debt increase in the quarter?
Teradyne drew $200 million on its revolving credit facility in Q3, which is classified as short-term debt on the balance sheet. Cash also declined because the company repurchased $243.8 million of common stock and invested $20.2 million in businesses, while operating cash flow was only $49.1 million due to a large receivables increase. Year to date, cash and equivalents fell by $280.7 million.
What should investors watch regarding receivables and working capital?
Accounts receivable climbed to $593.8 million from $471.4 million at year-end 2024, and the Q3 increase alone was $161.3 million. Inventories and prepayments also rose. Because the Q4 guidance implies a large revenue step-up, investors should watch whether receivables convert to cash in Q4 and whether the company's working capital and operating cash flow recover to support buybacks and dividends.
How do GAAP and non-GAAP results differ for Teradyne this quarter?
Non-GAAP net income of $135.9 million ($0.85 per diluted share) excludes acquired intangible amortization, equity method investment amortization of $7.7 million, restructuring and other charges of $6.6 million, ERP-related expenses, and a pension gain, with a related tax adjustment. The gap between GAAP EPS of $0.75 and non-GAAP EPS of $0.85 is mostly equity method amortization and restructuring. Management presents non-GAAP measures as supplemental, not as substitutes for GAAP results.

04—Continue

← View all 8-K filings